References
Arthus M (1903) Injections répétées de sérum de cheval chez le lapin. Comptes Rendus de la Societé de Biologie 55: 817–820.
Behring E and Kitasato S (1890) On the mechanism of immunity to diphtheria and tetanus in animals. Deutsche Medizinische Wochenschrift 16: 1113–1114.
Boross P, van Montfoort N, Stapels DA, et al. (2014) FcRgamma‐chain ITAM signaling is critically required for cross‐presentation of soluble antibody‐antigen complexes by dendritic cells. Journal of Immunology 193: 5506–5514.
Botto M, Dell'agnola C, Bygrave AE, et al. (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nature Genetics 19: 56–59.
Casciola‐Rosen LA, Anhalt G and Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. Journal of Experimental Medicine 179: 1317–1330.
Davies KA and Norsworthy P (2000) Autoantibodies to complement components. Methods in Molecular Biology 150: 173–192.
Davies KA, Robson MG, Peters AM, et al. (2002) Defective Fc‐dependent processing of immune complexes in patients with systemic lupus erythematosus. Arthritis and Rheumatism 46: 1028–1038.
Edwards JC and Cambridge G (1998) Rheumatoid arthritis: the predictable effect of small immune complexes in which antibody is also antigen. British Journal of Rheumatology 37: 126–130.
Kaech SM and Ahmed R (2001) Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nature Immunology 2: 415–422.
Kalergis AM and Ravetch JV (2002) Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. Journal of Experimental Medicine 195: 1653–1659.
Kim SJ, Gershov D, Ma X, Brot N and Elkon KB (2002) I‐PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. Journal of Experimental Medicine 196: 655–665.
Leon B, Ballesteros‐Tato A, Randall TD and Lund FE (2014) Prolonged antigen presentation by immune complex‐binding dendritic cells programs the proliferative capacity of memory CD8 T cells. Journal of Experimental Medicine 211: 1637–1655.
Pendergraft WF 3rd Preston GA, Shah RR, et al. (2004) Autoimmunity is triggered by cPR‐3(105–201), a protein complementary to human autoantigen proteinase‐3. Nature Medicine 10: 72–79.
Schuurhuis DH, van Montfoort N, Ioan‐Facsinay A, et al. (2006) Immune complex‐loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. Journal of Immunology 176: 4573–4580.
Sullivan KE, Jawad AF, Piliero LM, et al. (2003) Analysis of polymorphisms affecting immune complex handling in systemic lupus erythematosus. Rheumatology (Oxford) 42: 446–452.
van Montfoort N, T Hoen PA, Mangsbo SM, et al. (2012) Fcgamma receptor IIb strongly regulates Fcgamma receptor‐facilitated T cell activation by dendritic cells. Journal of Immunology 189: 92–101.
Waaler E (1940) On the occurrence of a factor in human serum activating the specific agglutination of sheep red blood corpuscles. Acta Pathologica et Microbiologica Scandinavia 17: 172–188.
Further Reading
Behnen M, Leschczyk C, Moller S, et al. (2014) Immobilized immune complexes induce neutrophil extracellular trap release by human neutrophil granulocytes via FcgammaRIIIB and Mac‐1. Journal of Immunology 193: 1954–1965.
Davies KA (1996) Complement, immune complexes and systemic lupus erythematosus. British Journal of Rheumatology 35: 5–23.
Janczy JR, Ciraci C, Haasken S, et al. (2014) Immune complexes inhibit IL‐1 secretion and inflammasome activation. Journal of Immunology 193: 5190–5198.
Lawley TJ (1995) Immune complexes. In: Frank MM, Austin K, Claman HN and Unanue ER, (eds). Smaster's Immunologic Diseases, 5th edn, pp. 321–330. Boston: Little Brown.
Maddison PJ and Huey P (2004) Serological profile. In: Isenberg DA, Maddison PJ, Woo P, Glass D and Breedveld FC, (eds). Oxford Textbook of Rheumatology, 3rd edn, pp. 491–499. Oxford: Oxford University Press.
Rojko JL, Evans MG, Price SA, et al. (2014) Formation, clearance, deposition, pathogenicity, and identification of biopharmaceutical‐related immune complexes: review and case studies. Toxicologic Pathology 42: 725–764.
Platzer B, Stout M and Fiebiger E (2014) Antigen cross‐presentation of immune complexes. Frontiers in Immunology 5: 140.
Rosen A and Cascioloa‐Rosen L (2003) Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. In: Kalden JR and Herrmann M, (eds). Apoptosis and Autoimmunity from Mechanisms to Treatments, 1st edn, pp. 245–261. Weinheim: Wiley.
Wener MH (2014) Tests for circulating immune complexes. Methods in Molecular Biology 1134: 47–57.